Nurix Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
485
across all filing types
Latest filing
2026-05-15
Regulatory Filings
Country
US
United States of America
Listing
US
NRIX
Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of medicines based on targeted protein degradation. The company's proprietary DEL-AI drug discovery engine is used to create therapies that harness the body's natural cellular machinery to eliminate disease-causing proteins. Its pipeline features multiple modalities, including small molecule degraders and Degrader Antibody Conjugates (DACs), which combine the specificity of an antibody with the catalytic potency of a degrader. These investigational therapies are being advanced for the treatment of various cancers and autoimmune diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-15 | English | |
| 10-Q - Nurix Therapeutics, Inc. (0001549595) (Filer) | 2026-04-08 | English | |
| 8-K - Nurix Therapeutics, Inc. (0001549595) (Filer) | 2026-04-08 | English | |
| SCHEDULE 13G/A - Nurix Therapeutics, Inc. (0001549595) (Subject) | 2026-03-27 | English | |
| ARS - Nurix Therapeutics, Inc. (0001549595) (Filer) | 2026-03-27 | English | |
| DEFA14A - Nurix Therapeutics, Inc. (0001549595) (Filer) | 2026-03-27 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46361664 | 8-K | 2026-05-15 | English | ||
| 33801814 | 10-Q - Nurix Therapeutics, Inc. (0001549595) (Filer) | 2026-04-08 | English | ||
| 33801779 | 8-K - Nurix Therapeutics, Inc. (0001549595) (Filer) | 2026-04-08 | English | ||
| 33062326 | SCHEDULE 13G/A - Nurix Therapeutics, Inc. (0001549595) (Subject) | 2026-03-27 | English | ||
| 33057550 | ARS - Nurix Therapeutics, Inc. (0001549595) (Filer) | 2026-03-27 | English | ||
| 33057619 | DEFA14A - Nurix Therapeutics, Inc. (0001549595) (Filer) | 2026-03-27 | English | ||
| 33057567 | DEF 14A - Nurix Therapeutics, Inc. (0001549595) (Filer) | 2026-03-27 | English | ||
| 32893678 | 4 - NURIX THERAPEUTICS, INC. (0001549595) (Filer) | 2026-03-03 | English | ||
| 30505731 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 18848146 | 4 - Nurix Therapeutics, Inc. (0001549595) (Issuer) | 2026-02-10 | English | ||
| 30505791 | 4 Filing | 2026-02-10 | English | ||
| 30505758 | 4 Filing | 2026-02-10 | English | ||
| 30505741 | 4 Filing | 2026-02-10 | English | ||
| 30505570 | 4 Filing | 2026-02-10 | English | ||
| 30505796 | 4 Filing | 2026-02-03 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ACROBIOSYSTEMS CO.,LTD.
Provides recombinant proteins and reagents for life science…
|
301080 | CN | Professional, scientific and te… |
|
ACTINOGEN MEDICAL LIMITED
Developing cortisol-inhibiting therapies for Alzheimer's an…
|
ACW | AU | Professional, scientific and te… |
|
Active Biotech
Biotechnology company developing drugs for oncology and inf…
|
ACTI | SE | Professional, scientific and te… |
|
Adagene Inc.
Clinical-stage biotech developing antibody-based immunother…
|
ADAG | KY | Professional, scientific and te… |
|
ADALTA LIMITED
Clinical-stage biotech developing i-body protein therapeuti…
|
1AD | AU | Professional, scientific and te… |
|
Adaptive Biotechnologies Corp
Decodes the adaptive immune system to develop products for …
|
ADPT | US | Professional, scientific and te… |
|
Adeia Inc.
R&D company that licenses IP for the media, entertainment, …
|
ADEA | US | Professional, scientific and te… |
|
Aditxt, Inc.
Acquires, develops, and deploys health technologies to addr…
|
ADTX | US | Professional, scientific and te… |
|
Advanced Biomed Inc.
Develops microfluidic biochip diagnostic systems for precis…
|
ADVB | US | Professional, scientific and te… |
|
Advanced Proteome Therapeutics Corporation
Develops proprietary technology for chemical modification o…
|
APC.H | CA | Professional, scientific and te… |
Nurix Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32519/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32519 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32519 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32519 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32519}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Nurix Therapeutics, Inc. (id: 32519)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.